154 Results for "

PLA 2

" in MedChemExpress (MCE) Product Catalog:
Products (154)

154 Results for "PLA 2" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-P0233
CAS No.: 20449-79-0
Target:  

Phospholipase

Research Areas:  

Inflammation/Immunology Cancer

Melittin is a PLA2 activator, stimulates the activity of the low molecular weight PLA2, while it does not the increase activity of the high molecular weight PLA2 .
loading...
    loading...
17
17 Publications Verification
Cat. No.: HY-P0233A
Target:  

Phospholipase

Research Areas:  

Infection Cancer

Melittin TFA is a PLA2 activator, stimulates the activity of the low molecular weight PLA2, while it does not the increase activity of the high molecular weight PLA2 .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-10521
CAS No.: 356057-34-6
Purity:  99.94%
Synonyms: SB-480848
Target:  

Phospholipase Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

Darapladib (SB-480848) is an orally active, selective and reversible Lp-PLA2 inhibitor (IC50=0.25 nM). Darapladib can trigger irreversible actions on glioma cell apoptosis and induce cycle arrest. Darapladib can be used in the study of atherosclerosis and cancer .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-118628
CAS No.: 110683-10-8
Purity:  99.63%
Synonyms: N-(p-Amylcinnamoyl) anthranilic acid; ACA
Research Areas:  

Cardiovascular Disease

(E/Z)-BML264 (N-(p-amylcinnamoyl) Anthranilic Acid) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker . (E/Z)-BML264 is a SLC13A3 inhibitor. (E/Z)-BML264 (N-(p-amylcinnamoyl) Anthranilic Acid) is also an effective reversible inhibitor of calcium-activated chloride channels, has potential to treat arrhythmia .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-18705
CAS No.: 932986-18-0
Azoramide is a potent, orally active small-molecule modulator of the unfolded protein response (UPR). Azoramide improves ER protein folding and elevates ER chaperone capacity, which together protects cells against ER stress. Azoramide alleviates PLA2G6 mutant-induced ER stress through modulating unfolded protein response, and enhances the CERB signaling to rescue mitochondrial function, thereby preventing apoptosis of DA neurons. Azoramide has antidiabetic activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P74628
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Phospholipase A2, membrane associated; EF; GIIC sPLA2
Species:  
Source:  
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-102004
CAS No.: 412950-08-4
Purity:  99.44%
Synonyms: SB 659032
Rilapladib (SB 659032) is a selective Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor with an IC50 of 230 pM . Rilapladib (SB 659032) is also a PAFR (Platelet Activating Factor Receptor) antagonist .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-122949
CAS No.: 91590-76-0
Purity:  ≥97.0%
Momordicine I is a cucurbitane-type triterpenoids. Momordicine I suppresses glioma growth by promoting apoptosis and impairing mitochondrial oxidative phosphorylation. Momordicine I inhibits glycolysis, lipid metabolism, induces autophagy in HNC cells to suppress head and neck cancer growth. Momordicine I alleviates isoproterenol-induced cardiomyocyte hypertrophy through suppression of PLA2G6 and DGK-ζ. Momordicine I exerts its cardiovascular benefits by upregulating nitric oxide, inhibiting the activity of angiotensin-converting enzyme (ACE), activating the PI3K/Akt pathway, reducing oxidative stress and inflammation. Momordicine I inhibits AKT1, IL-6, and SRC, suggesting its potential application in type 2 diabetes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P3029
CAS No.: 9001-84-7
Synonyms: PLA2
Phospholipase A2 (PLA2) is a calcium-dependent, heat-stable enzyme that catalyzes the hydrolysis of glycerophospholipids at the sn-2 position of cellular membranes, thereby releasing Arachidonic Acid (AA) (HY-109590). Phospholipase A2 is a key mediator in the biosynthesis of pro-inflammatory lipid mediators, critically involved in inflammatory processes. Phospholipase A2 can be used for cardiovascular and inflammatory diseases research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-17448
CAS No.: 172733-08-3
Synonyms: A-002; LY333013
Target:  

Phospholipase

Research Areas:  

Inflammation/Immunology

Varespladib methyl (A-002; LY333013) is a selective inhibitor of group II secretory phospholipase A2 (PLA2).
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P71071
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PLA2G1B; Phospholipase A2; Group IB phospholipase A2; PLA2; PLA2A; PPLA2
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18570
CAS No.: 86-87-3
Synonyms: 1-Naphthylacetic acid
1-Naphthaleneacetic acid (1-Naphthylacetic acid), a auxin, can promote plant growth. 1-Naphthaleneacetic acid is also an inhibitor of PLA2, with an IC50 of 13.16 μM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18570A
CAS No.: 15165-79-4
Synonyms: Potassium 1-Naphthaleneacetate
Research Areas:  

Others

1-Naphthaleneacetic acid potassium salt (Potassium 1-Naphthaleneacetate), a synthetic auxin, can promote plant growth. 1-Naphthaleneacetic acid potassium salt is also an inhibitor of PLA2, with an IC50 of 13.16 μM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W329357
CAS No.: 108273-89-8
15:0 Lyso PC is a lysophosphatidylcholine (Lyso PC), a product of phospholipase A2 (PLA2) hydrolysis of phosphatidylcholine (PC) and is involved in cell membrane remodeling and inflammatory signaling. 15:0 Lyso PC demonstrates significant lipid metabolism disturbances in the serum with ischemic heart disease (IHD) and ischemic cardiomyopathy (ICM). 15:0 Lyso PC can be used as a lipid biomarker for cardiovascular disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125254
CAS No.: 2313525-90-3
Purity:  99.72%
Target:  

HRASLS Phospholipase

Research Areas:  

Metabolic Disease Cancer

LEI110 is a pan-inhibitor of the HRASLS family and an inhibitor of AP-2α, with a Ki of 20 nM against PLA2G16. LEI110 exhibits inhibitory activity against PLA2G16, HRASLS2, RARRES3 and iNAT, with pIC50 values of 7.0, 6.8, 6.8 and 7.6, respectively. LEI110 binds to the active site of PLA2G16, reduces intracellular arachidonic acid levels, and attenuates oleic acid-induced lipolysis. LEI110 stabilizes AP-2α, impairs its DNA-binding ability, inhibits the transcription of DNA damage repair genes, induces the accumulation of oxidative DNA damage, suppresses cell proliferation and clonogenicity, and sensitizes HCC cells to DNA-damaging agents. LEI110 can be used in research related to obesity, fatty liver disease, the common cold and hepatocellular carcinoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18540
CAS No.: 1402612-55-8
Target:  

MAGL DAGL

KT109 is a potent and an isoform-selective inhibitor of diacylglycerol lipase-β (DAGLβ) with an IC50 of 42 nM. KT109 has ~60-fold selectivity for DAGLβ over DAGLα. KT109 shows inhibitory activity against PLA2G7 (IC50=1 µM). KT109 shows negligible activity against FAAH, MGLL, ABHD11, and cytosolic phospholipase A2 (cPLA2 or PLA2G4A). KT109 perturbs a lipid network involved in macrophage inflammatory responses and lowers 2-Arachidonoylglycerol (HY-W011051), Arachidonic acid (HY-109590) and eicosanoids in mouse peritoneal macrophages .
loading...
    loading...
Cat. No.: HY-115062
CAS No.: 1007476-63-2
Purity:  ≥99.0%
MJ-33 lithium salt is a competitive phospholipase A2 (PLA2) inhibitor with an IC50 of 0.3 μM. MJ-33 lithium salt inhibits NOX2 activation and reduces ROS production by blocking the PLA2 activity of Prdx6. MJ-33 lithium salt effectively inhibits the activity of acidic PLA2 (pH 4.0) and reduces the degradation of alveolar surfactant phosphatidylcholine (PC), but exerts no effect on alkaline PLA2 (pH 8.5). MJ-33 lithium salt significantly alleviates lung oxidative injury induced by ischemia-reperfusion (I/R). MJ-33 lithium salt significantly inhibits the invasion, migration and adhesion abilities of prostate cancer cells by suppressing the MAPK, AKT, NF-κB and AP-1 signaling pathways. MJ-33 lithium salt can be used for the research of ROS-related diseases and prostate cancer .
loading...
    loading...
Cat. No.: HY-P3029A
CAS No.: 9001-84-7
Synonyms: PLA2, Crotalus adamanteus Venom
Target:  

Phospholipase

Research Areas:  

Others

Phospholipase A2 (PLA2), Crotalus adamanteus Venom is a membrane phospholipid-targeting enzyme. Phospholipase A2, Crotalus adamanteus catalyzes cleavage of the sn-2-acyl bond of membrane phospholipids, producing lysophospholipids and free fatty acids. Phospholipase A2, Crotalus adamanteus Venom can be used for biochemical research .
loading...
    loading...
Cat. No.: HY-123070
CAS No.: 99754-06-0
Purity:  99.31%
Target:  

Phospholipase

Research Areas:  

Inflammation/Immunology

ONO-RS-082 is an inhibitor of phospholipase A (PLA) . ONO-RS-082 inhibits PLA2 with the IC50 of 1.0 μM, but does not inhibit PLC even at 100 μM .
loading...
    loading...
Cat. No.: HY-19757
CAS No.: 1420367-28-7
Lp-PLA2-IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2-IN-1 has the potential for atherosclerosis, Alzheimer's disease research .
loading...
    loading...